Figure 4
From: A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer
Prior and Stage 2 posterior distributions for the previously treated group.
Figure 4 | British Journal of Cancer
From: A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer
Prior and Stage 2 posterior distributions for the previously treated group.
